University of Antwerp

About: University of Antwerp is a education organization based out in Antwerp, Belgium. It is known for research contribution in the topics: Population & Context (language use). The organization has 16682 authors who have published 48837 publications receiving 1689748 citations. The organization is also known as: Universiteit Antwerpen & UAntwerp.

A New Winning Formula?: The Programmatic Appeal of the Radical Right

Abstract: In an updated version of his well-known work on the radical right, Kitschelt attributes the persistent success of this type of party to a new winning formula. Where the radical right first campaigned on a neo-liberal and authoritarian programme, it now presents a more centrist economic position. The article tests this idea through a reconstruction of the positions of the French Front National, the Flemish Vlaams Blok and the Dutch Lijst Pim Fortuyn, and establishes that some, but not all, radical right parties make use of the new winning formula. Moreover, innovative analysis of the positions of radical right parties in West European party systems reveals that Kitschelt's theory needs to be improved on several points, most notably when it comes to the definition of concepts and the operationalization of dimensions.

Failure of familial Alzheimer's disease to segregate with the A4-amyloid gene in several European families.

Abstract: The gene coding for the amyloid protein, a component of neuritic plaques found in brain tissue from patients with Alzheimer's disease, has been localized to chromosome 21, and neighbouring polymorphic DNA markers segregate with Alzheimer's disease in several large families. These data, and the association of Alzheimer's disease with Down's syndrome, suggest that overproduction of the amyloid protein, or production of an abnormal variant of the protein, may be the underlying pathological change causing Alzheimer's disease. We have identified a restriction fragment length polymorphism of the A4-amyloid gene, and find recombinants in two Alzheimer's disease families between Alzheimer's disease and the A4-amyloid locus. This demonstrates that the gene for plaque core A4-amyloid cannot be the locus of a defect causing Alzheimer's disease in these families. These data indicate that alterations in the plaque core amyloid gene cannot explain the molecular pathology for all cases of Alzheimer's disease.

3-methyl-1,2,3-butanetricarboxylic acid: An atmospheric tracer for terpene secondary organic aerosol

Abstract: [1] Highly oxygenated compounds assigned to be oxidation products of α-pinene have recently been observed in substantial concentrations in ambient aerosols. Here, we confirm the unknown α-pinene tracer compound with molecular weight (MW) 204 as the C8-tricarboxylic acid 3-methyl-1,2,3-butanetricarboxylic acid. Its gas and liquid chromatographic behaviors and its mass spectral characteristics in electron ionization and negative ion electrospray ionization perfectly agree with those of a synthesized reference compound. The formation of this compound is explained by further reaction of cis-pinonic acid involving participation of the OH radical. This study illustrates that complex, multi-generation chemistry holds for the photooxidation of α-pinene in the presence of NOx.

VHL and HIF signalling in renal cell carcinogenesis

Abstract: Hypoxia-inducible factor (HIF) plays an important role in renal tumourigenesis. In the majority of clear cell RCC (ccRCC), the most frequent and highly vascularized RCC subtype, HIF is constitutively activated by inactivation of the von Hippel-Lindau gene. Of the HIF subunits, HIF-2alpha appears to be more oncogenic than HIF-1alpha, in that HIF-2alpha activates pro-tumourigenic target genes. In addition, recent studies indicate that HIF-1alpha, more than HIF-2alpha, can undergo proteasomal degradation in VHL - /- RCC cells. A more detailed understanding of the molecular basis of hypoxia and angiogenesis in renal carcinogenesis has set the stage for the development of targeted therapies, inhibiting multiple HIF-related pathways, such as the phosphatidylinositol 3-kinase-AKT-mTOR, RAS/RAF/MAP, and VEGF signalling routes. However, despite the positive results of these targeting agents in progression-free survival, clinical resistance remains an issue. Recent pre-clinical studies have suggested new targeting approaches such as inhibition of HIF-driven key metabolic enzymes and have introduced new HIF targeting agents, such as histone deacetylase inhibitors, with successful anti-neoplastic effects. In this review, we discuss existing and novel findings about RCC carcinogenesis, with subsequent clinical implications.